Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-26-000148 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
133.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.04% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.04% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-2.95% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
47.80% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
41.21% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.49% · CORE · VALID
R&D intensity 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.54% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.64% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Mar 31, 2019 8/8 normalized Level 3 Jun 30, 2019 7/7 normalized Level 3 Sep 30, 2019 8/8 normalized Level 3 Dec 31, 2019 8/8 normalized Level 3 Mar 31, 2020 8/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Dec 31, 2020 8/8 normalized Level 3 Mar 31, 2021 8/8 normalized Level 3 Jun 30, 2021 8/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 126.16%
Current 133.71%
Delta 7.56% Capex Intensity Increased
Previous 3.81%
Current 4.04%
Delta 0.23% Cash Generation Increased
Previous 12.41%
Current 15.04%
Delta 2.62% Growth Decreased
Previous 1.52%
Current -2.95%
Delta -4.48% Inventory Pressure Increased
Previous 43.49%
Current 47.80%
Delta 4.30% Margin Decreased
Previous 41.22%
Current 41.21%
Delta -0.02% Profitability Increased
Previous 16.70%
Current 17.49%
Delta 0.80% R And D Intensity Increased
Previous 2.53%
Current 2.54%
Delta 0.02% Sbc Intensity Increased
Previous 0.51%
Current 0.64%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2026
Similarity 78%
Compared 8 dimensions
Coverage 100% Growth 15.0 · Margin 5.0 · Profitability 0.0 · Sbc Intensity 50.0 · Capex Intensity 15.0 · Cash Generation 25.0 · R And D Intensity 5.0 · Inventory Pressure 20.0 Jun 30, 2025
Similarity 76%
Compared 8 dimensions
Coverage 100% Growth 40.0 · Margin 0.0 · Profitability 5.0 · Sbc Intensity 40.0 · Capex Intensity 10.0 · Cash Generation 25.0 · R And D Intensity 20.0 · Inventory Pressure 20.0 Sep 30, 2016
Similarity 75%
Compared 7 dimensions
Coverage 88% Margin 5.0 · Profitability 33.3 · Sbc Intensity 38.9 · Capex Intensity 23.3 · Cash Generation 15.0 · R And D Intensity 2.2 · Inventory Pressure 32.8 Dec 31, 2025
Similarity 73%
Compared 8 dimensions
Coverage 100% Growth 30.0 · Margin 15.0 · Profitability 5.0 · Sbc Intensity 25.0 · Capex Intensity 35.0 · Cash Generation 20.0 · R And D Intensity 15.0 · Inventory Pressure 45.0 Jun 30, 2019
Similarity 72%
Compared 7 dimensions
Coverage 88% Growth 43.8 · Margin 30.0 · Profitability 25.0 · Sbc Intensity 5.0 · Capex Intensity 10.0 · R And D Intensity 40.0 · Inventory Pressure 20.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.